Security Snapshot

DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) Institutional Ownership

CUSIP: 23725P308

13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

21

Shares (Excl. Options)

856,736

Price

$6.60

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+14,129
Value change
+$92,578
Number of holders
21
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
6,893,624
SEC-reported price per share
$7.90
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share is tracked under CUSIP 23725P308.
  • 21 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 21 to 21 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $6,757,585 to $5,654,514.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 21 institutions filings for Q2 2026.

Open SEC evidence

Security key

23725P308

Latest holder period

Q2 2026

13F holders

21

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
DRIO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% 0% $8,098,794 +$1,409,189 688,673 +21% Nantahala Capital Management, LLC 31 Dec 2025
Nantahala Capital Partners Limited Partnership 4.6% $5,491,128 316,497 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025

As of 30 Jun 2026, 21 institutional investors reported holding 856,736 shares of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO). This represents 12% of the company’s total 6,893,624 outstanding shares.

13F concentration

Top 23 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
12%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.9% 610,691 +0% 0.24% $4,030,561
VANGUARD CAPITAL MANAGEMENT LLC 0.95% 65,675 -0.36% 0% $433,455
GEODE CAPITAL MANAGEMENT, LLC 0.84% 58,035 -6.2% 0% $383,271
BlackRock, Inc. 0.55% 37,796 +101% 0% $249,454
VANGUARD FIDUCIARY TRUST CO 0.54% 37,387 +24% 0% $246,754
CITADEL ADVISORS LLC 0.35% 24,289 +19% 0% $160,307
NORTHERN TRUST CORP 0.19% 13,237 0% 0% $87,365
Vanguard Global Advisers, LLC 0.05% 3,321 0% 0% $21,919
MORGAN STANLEY 0.04% 3,000 +200% 0% $19,800
OSAIC HOLDINGS, INC. 0.03% 1,900 +189900% 0% $12,540
ROYAL BANK OF CANADA 0.01% 633 +50% 0% $4,000
TRUST CO OF TOLEDO NA /OH/ 0.01% 352 0% 0% $2,323
FIDUCIARY FINANCIAL ADVISORS 0% 159 0% $1,043
UBS Group AG 0% 139 -99% 0% $917
SBI Securities Co., Ltd. 0% 69 -2.8% 0% $455
BARCLAYS PLC 0% 26 0% $172
Steward Partners Investment Advisory, LLC 0% 10 0% 0% $66
BNP PARIBAS FINANCIAL MARKETS 0% 9 0% 0% $59
WELLS FARGO & COMPANY/MN 0% 5 0% 0% $33
Caitong International Asset Management Co., Ltd 0% 2 +100% 0% $13
JPMORGAN CHASE & CO 0% 1 0% 0% $7
CITIGROUP INC 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Latest
Q2 2026
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 856,736 $5,654,514 +$92,578 $6.60 21
2026 Q1 842,607 $6,757,585 +$849,454 $8.02 21
2025 Q4 735,327 $8,367,910 +$367,337 $11.38 17
2025 Q3 673,152 $11,679,174 +$11,679,018 $17.35 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .